杨森新冠疫苗接种后焦虑相关不良事件聚集性报告
2021年4月7日至9日,美国五个州的大规模疫苗接种点报告杨森新冠疫苗接种后焦虑相关事件聚集,共64例焦虑相关事件(含17例晕厥),涉及8624名受种者。CDC分析VAERS数据发现杨森疫苗后晕厥报告率为8.2例/10万剂,而2019-20流感季流感疫苗后晕厥报告率为0.05例/10万剂。建议接种后至少观察15分钟。
要点
- 杨森新冠疫苗接种后焦虑相关事件(含晕厥)报告率高于流感疫苗。
- 接种后应观察所有受种者至少15分钟以监测不良反应。
- 接种提供者应知晓焦虑相关不良事件可能更频繁报告。
核心结论
- 杨森新冠疫苗接种后焦虑相关不良事件(包括晕厥)的报告率高于流感疫苗接种后。
研究设计与样本
- CDC对五个大规模接种点的工作人员进行访谈,并分析VAERS中杨森疫苗接种后晕厥报告,与2019-20流感季流感疫苗后晕厥报告比较。
主要发现
- 2021年4月7日至9日,五个接种点共报告64例焦虑相关事件,包括17例晕厥,涉及8624名杨森疫苗接种者。
- 杨森疫苗接种后晕厥报告率为8.2例/10万剂,流感疫苗接种后为0.05例/10万剂。
关键数值与推荐
- 接种杨森新冠疫苗后应观察所有受种者至少15分钟。
临床怎么用
- 接种提供者应意识到焦虑相关事件可能发生,并确保接种后观察至少15分钟。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
On April 7, 2021, after 5 weeks' use of the Janssen COVID-19 vaccine under the Food and Drug Administration (FDA) Emergency Use Authorization (EUA), CDC received reports of clusters of anxiety-related events after administration of Janssen COVID-19 vaccine from five mass vaccination sites, all in different states. To further investigate these cases, CDC interviewed vaccination site staff members to gather additional information about the reported events and vaccination site practices. Four of the five sites temporarily closed while an investigation took place. Overall, 64 anxiety-related events, including 17 reports of syncope (fainting), an anxiety-related event, among 8,624 Janssen COVID-19 vaccine recipients, were reported from these sites for vaccines administered during April 7-9. As a follow-up to these interviews, CDC analyzed reports of syncope shortly after receipt of Janssen COVID-19 vaccine to the Vaccine Adverse Event Reporting System (VAERS), the vaccine safety monitoring program managed by CDC and FDA. To compare the occurrence of these events with those reported after receipt of other vaccines, reports of syncopal events after influenza vaccine administered in the 2019-20 influenza season were also reviewed. Syncope after Janssen COVID-19 vaccination was reported to VAERS (8.2 episodes per 100,000 doses). By comparison, after influenza vaccination, the reporting rate of syncope was 0.05 episodes per 100,000 doses. Anxiety-related events can occur after any vaccination. It is important that vaccination providers are aware that anxiety-related adverse events might be reported more frequently after receipt of the Janssen COVID-19 vaccine than after influenza vaccination and observe all COVID-19 vaccine recipients for any adverse reactions for at least 15 minutes after vaccine administration.
引用
- Hause AM, Gee J, Johnson T, et al. Anxiety-Related Adverse Event Clusters After Janssen COVID-19 Vaccination - Five U.S. Mass Vaccination Sites, April 2021. MMWR Morb Mortal Wkly Rep. 2021. PMID: 33956781. doi:10.15585/mmwr.mm7018e3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。